Agile Therapeutics, Inc. (AGRX)

Aug 26, 2024 - AGRX was delisted (reason: acquired by Insud Pharma)

1.510

0.00 (0.00%)

Inactive · Last trade price on Aug 26, 2024

Agile Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Aug '24 Aug 26, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Market Capitalization	10	5	9	59	251	148
Market Cap Growth	-	-46.88%	-84.44%	-76.39%	69.26%	648.87%
Enterprise Value	8	5	5	61	195	130
Last Close Price	1.51	1.95	11.35	976.20	5740.00	5000.00

Price Ratios

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Aug '24 Aug 26, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
PE Ratio	-	-0.29	-0.19	-0.67	-4.69	-6.64
PS Ratio	0.31	0.25	0.85	14.45	335.03	-
PB Ratio	-	-0.30	-1.66	15.13	5.09	3.24
P/FCF Ratio	-	-0.51	-0.26	-0.91	-5.26	-9.39
P/OCF Ratio	-	-0.51	-0.26	-0.91	-5.30	-9.45

EV Ratios

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Aug '24 Aug 26, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
EV/Sales Ratio	0.36	0.23	0.48	14.87	260.54	-
EV/EBITDA Ratio	-	-0.23	-0.13	-0.89	-4.00	-6.96
EV/EBIT Ratio	-	-0.23	-0.13	-0.86	-3.98	-6.90
EV/FCF Ratio	-	-0.47	-0.14	-0.93	-4.09	-8.24

Financial Efficiency

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Aug '24 Aug 26, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Debt / Equity Ratio	-0.01	-0.13	-0.40	4.54	0.33	0.00
Debt / FCF Ratio	-0.17	-0.23	-0.06	-0.27	-0.35	-0.01
Asset Turnover	1.57	1.60	0.41	0.07	0.01	-
Inventory Turnover	1.88	4.41	5.95	-	-	-
Quick Ratio	0.28	0.29	0.64	0.71	7.53	9.09
Current Ratio	0.55	0.46	0.85	0.82	7.72	9.31
Return on Equity (ROE)	-	-	-	-266.95%	-109.08%	-56.45%
Return on Assets (ROA)	-61.55%	-101.46%	-96.67%	-78.97%	-50.01%	-32.77%
Return on Invested Capital (ROIC)	-	-	-281.89%	-101.37%	-54.86%	-35.67%

Yields

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Aug '24 Aug 26, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Earnings Yield	-152.10%	-295.34%	-275.63%	-119.94%	-20.66%	-12.55%
FCF Yield	-16.36%	-195.54%	-391.34%	-110.49%	-18.99%	-10.65%
Buyback Yield / Dilution	-308.85%	-398.99%	-790.51%	-14.63%	-71.31%	-44.05%
Total Shareholder Return	-308.85%	-398.99%	-790.51%	-14.63%	-71.31%	-44.05%

SEC Filings: 10-K · 10-Q